The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like Curis To Release First Quarter 2017 Financial Results And Hold Conference Call On May 4, 2017 April 30, 2017 Meet the Under-the-Radar Biotech With a 'Novel' Alzheimer's Candidate November 20, 2017 Sysmex AmericaTo Distribute Erythrocyte Sedimentation Rate Products From Alifax S.p.A. February 19, 2017
Curis To Release First Quarter 2017 Financial Results And Hold Conference Call On May 4, 2017 April 30, 2017
Sysmex AmericaTo Distribute Erythrocyte Sedimentation Rate Products From Alifax S.p.A. February 19, 2017
